Werewolf Therapeutics, Inc. (HOWL)
0.9796
+0.07
(+7.65%)
USD |
NASDAQ |
Oct 09, 16:00
0.9792
0.00 (0.00%)
After-Hours: 20:00
Werewolf Therapeutics Net Income (Quarterly) : 3.67M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.67M |
| March 31, 2026 | -13.53M |
| December 31, 2025 | -8.381M |
| September 30, 2025 | -16.37M |
| June 30, 2025 | -17.98M |
| March 31, 2025 | -18.09M |
| December 31, 2024 | -20.40M |
| September 30, 2024 | -16.67M |
| June 30, 2024 | -17.25M |
| March 31, 2024 | -16.19M |
| December 31, 2023 | -12.00M |
| September 30, 2023 | -8.285M |
| Date | Value |
|---|---|
| June 30, 2023 | -5.098M |
| March 31, 2023 | -11.98M |
| December 31, 2022 | -11.93M |
| September 30, 2022 | -11.94M |
| June 30, 2022 | -14.59M |
| March 31, 2022 | -15.34M |
| December 31, 2021 | -17.87M |
| September 30, 2021 | -13.76M |
| June 30, 2021 | -10.92M |
| March 31, 2021 | -7.435M |
| December 31, 2020 | -7.402M |
| September 30, 2020 | -6.068M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 21.00M |
| Total Expenses (Quarterly) | 17.33M |
| EPS Diluted (Quarterly) | 0.0755 |
| Enterprise Value | 25.62M |
| Gross Profit Margin (Quarterly) | 88.32% |
| Profit Margin (Quarterly) | 17.48% |
| Earnings Yield | -75.40% |
| Normalized Earnings Yield | -66.01 |